JCPP Editorial: Volume 61, Issue 12, December 2020

Louie Sandys
Journal Operations Manager at ACAMH

Posted on

Editorial: Biomarkers in precision medicine for mental illnesses

Bradley S. Peterson


Precision medicine and biomarker development have become the prevailing paradigm for mental health research. Despite its conceptual elegance and dominance as a research framework, precision medicine has a very limited track record of demonstrable success thus far for mental illnesses, due in varying degrees to the complexity of both the brain and the pathophysiology of mental illnesses, which limits our ability to develop, replicate, and validate biomarkers for use in enhancing clinical care for mental illnesses, especially in high‐risk and complex clinical populations. Research and funding priorities should integrate biomarker development and precision medicine interventions that target the robust behavioral, environmental, and social determinants that we know are important for population‐based mental health.

We hope you enjoy the full editorial of this Issue, which is free on the Wiley Online Library.

Bradley Peterson
Professor Bradley Peterson

Professor Bradley Peterson, Director, Institute for the Developing Mind, The University of Southern California and Children’s Hospital Los Angeles; Director of the Division of Child and Adolescent Psychiatry, Keck School of Medicine, USC; Professor of Pediatrics, Keck School of Medicine of USC; joint editor of JCPP.

Add a comment

Your email address will not be published. Required fields are marked *